0001183740-13-000259.txt : 20130711 0001183740-13-000259.hdr.sgml : 20130711 20130711124918 ACCESSION NUMBER: 0001183740-13-000259 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130711 DATE AS OF CHANGE: 20130711 EFFECTIVENESS DATE: 20130711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EUPRAXIA PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001581178 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-199429 FILM NUMBER: 13963445 BUSINESS ADDRESS: STREET 1: 1240-666 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 2X8 BUSINESS PHONE: 604-685-0088 MAIL ADDRESS: STREET 1: 1240-666 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 2X8 D 1 primary_doc.xml X0706 D LIVE 0001581178 EUPRAXIA PHARMACEUTICALS INC. 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 604-685-0088 BRITISH COLUMBIA, CANADA Plaza Capital Partners Inc. None Corporation true 2012 DAVID STADNYK 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Director JAMES HELLIWELL 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Executive Officer Director JOHN MONTALBANO 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Director SIMON PIMSTONE 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Director PAUL GEYER 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Director MICHAEL WILMINK 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Director GEORGE TSAFALAS 1240-666 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2X8 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2012-12-21 true true true true false 0 ROBERT CAMERON SMITH 2757295 None None 132 NEWTON AVENUE NORWALK CT CONNECTICUT 06851 CT CONNECTICUT false 645089 376848 268241 13(a)=the price of the units (1,901,999 @ C$0.20), plus the aggregate exercise price of the warrants forming part of the units (951,000 @ C$0.25), plus the aggregate exercise price of certain finder's warrants and finder's unit warrants, converted to US$. false 14 0 0 Finder received 102,000 finder's units convertible to finder's unit warrants @ C$0.20 and 51,000 finder's warrants exercisable at C$0.25. All warrants are exercisable for a period of 24 months. 0 false EUPRAXIA PHARMACEUTICALS INC. /s/ George Tsafalas George Tsafalas Chief Financial Officer 2013-07-09